Survival rate of antitumour necrosis factor-α treatments for psoriasis in routine dermatological practice: a multicentre observational study

Dose-creep of Infliximab During Psoriasis Treatment: An Observational Study

(2013) C Mehren et al.   ACTA DERMATO-VENEREOLOGICA

Efficacy of etanercept for the treatment of psoriasis: an overview of the Italian clinical experience from the real-life setting and independent studies

(2012) Gino A. Vena et al.   IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY

Safety of anti-TNFα agents in the treatment of psoriasis and psoriatic arthritis

(2012) Giampiero Girolomoni et al.   IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY

Etanercept provides an effective, safe and flexible short- and long-term treatment regimen for moderate-to-severe psoriasis: a systematic review of current evidence

(2012) Robert Strohal et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Efficacy of systemic therapies for moderate-to-severe psoriasis: a systematic review and meta-analysis of long-term treatment

(2012) T.C. Lucka et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Drug survival rates of biologic treatments in patients with psoriasis vulgaris

(2011) A.M.G. Brunasso et al.   BRITISH JOURNAL OF DERMATOLOGY

Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris

(2011) R. Gniadecki et al.   BRITISH JOURNAL OF DERMATOLOGY

Factors affecting adherence to treatment of psoriasis: comparing biologic therapy to other modalities

(2011) Sue Ann Chan et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Treatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti-tumor necrosis factor α therapy: Results from the nationwide Danish DANBIO registry

(2010) Bente Glintborg et al.   ARTHRITIS AND RHEUMATISM

Sustained Clinical Response in Psoriatic Arthritis Patients Treated with Anti-TNF Agents: A 5-year Open-Label Observational Cohort Study

(2010) Ioanna Saougou et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome

(2009) R.J.B. Driessen et al.   BRITISH JOURNAL OF DERMATOLOGY

European S3-Guidelines on the systemic treatment of psoriasis vulgaris

(2009) D Pathirana et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Persistence with anti-tumor necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics Register

(2009) Amr A Saad et al.   ARTHRITIS RESEARCH & THERAPY

Biologic therapies for psoriasis: practical experience in a U.K. tertiary referral centre

(2008) R.B. Warren et al.   BRITISH JOURNAL OF DERMATOLOGY